David Turkaly
Stock Analyst at Citizens
(2.31)
# 2,657
Out of 5,245 analysts
154
Total ratings
42.25%
Success rate
-2.23%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Market Outperform | $85 → $115 | $103.00 | +11.65% | 12 | May 8, 2026 | |
| MDXG MiMedx Group | Maintains: Market Outperform | $7 → $6 | $3.62 | +65.75% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $120 → $105 | $85.50 | +22.81% | 15 | Apr 29, 2026 | |
| AXGN Axogen | Maintains: Market Outperform | $42 → $50 | $40.90 | +22.25% | 10 | Apr 29, 2026 | |
| TELA TELA Bio | Maintains: Market Outperform | $5 → $3 | $0.8901 | +237.04% | 8 | Mar 27, 2026 | |
| SYK Stryker | Upgrades: Market Outperform | $440 | $316.48 | +39.03% | 4 | Dec 19, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $4.13 | +93.70% | 6 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $18.40 | +35.91% | 12 | Oct 10, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $10.75 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $84.81 | - | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $100 | $65.49 | +52.70% | 12 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $265 → $280 | $216.57 | +29.29% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $15.10 | +65.56% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $24.19 | +127.37% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $663.46 | -24.64% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $132.75 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $14.68 | +117.98% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $5.72 | +179.72% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.20 | +150.00% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $10.10 | -50.50% | 1 | Oct 6, 2017 |
Lantheus Holdings
May 8, 2026
Maintains: Market Outperform
Price Target: $85 → $115
Current: $103.00
Upside: +11.65%
MiMedx Group
Apr 30, 2026
Maintains: Market Outperform
Price Target: $7 → $6
Current: $3.62
Upside: +65.75%
Zimmer Biomet Holdings
Apr 29, 2026
Maintains: Market Outperform
Price Target: $120 → $105
Current: $85.50
Upside: +22.81%
Axogen
Apr 29, 2026
Maintains: Market Outperform
Price Target: $42 → $50
Current: $40.90
Upside: +22.25%
TELA Bio
Mar 27, 2026
Maintains: Market Outperform
Price Target: $5 → $3
Current: $0.8901
Upside: +237.04%
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $316.48
Upside: +39.03%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $4.13
Upside: +93.70%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $18.40
Upside: +35.91%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $10.75
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $84.81
Upside: -
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $65.49
Upside: +52.70%
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $216.57
Upside: +29.29%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $15.10
Upside: +65.56%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $24.19
Upside: +127.37%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $663.46
Upside: -24.64%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $132.75
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $14.68
Upside: +117.98%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $5.72
Upside: +179.72%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.20
Upside: +150.00%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $10.10
Upside: -50.50%